PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation
Albring J., Inselmann S., Sauer T., Schliemann C., Altvater B., Kailayangiri S., Rössig C., Hartmann W., Knorrenschild J., Sohlbach K., Groth C., Lohoff M., Neubauer A., Berdel W., Burchert A., Stelljes M.
Research article (journal) | Peer reviewedDetails about the publication
Journal: Bone Marrow Transplantation
Volume: 52
Issue: 2
Page range: 317-320
Status: Published
Release year: 2017
Language in which the publication is written: English
DOI: 10.1038/bmt.2016.274
Link to the full text: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84997707920&origin=inward
Keywords: Programmed Cell Death 1 Receptor
Authors from the University of Münster
| Albring, Jörn Christian | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
| Altvater, Bianca | University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO) |
| Hartmann, Wolfgang | Gerhard Domagk Institute of Pathology |
| Rössig, Claudia | University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO) |
| Schliemann, Christoph | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |